Kwality Pharmaceuticals Current Share Price | Kwality Pharmaceuticals Stock Screener
KPL
Pharmaceuticals
Kwality Pharmaceuticals Current Stock Price Today
Live Share Price NSE
₹3471.20
▲
19.10 (0.55%)
Live Share Price BSE
₹3475.40
▲
24.05 (0.70%)
As of September 18, 2026, the live Kwality Pharmaceuticals share price (NSE: KPL) is ₹3,471.20 on NSE and ₹3,475.40 on BSE, up 0.55% from the previous close, with shares trading between ₹3,430.10 and ₹3,564.90 in today's trading session, and a 52-week range of ₹1,579.55–₹3,661.40.
Browse Kwality Pharmaceuticals annual reports to support your investment research.
Use the Kwality Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Kwality Pharmaceuticals Market Cap
₹3,687.08 Cr.
KPL P/E Ratio (TTM)
46.63
Kwality Pharmaceuticals P/B Ratio
11.02
EPS (TTM)
₹64.90
Dividend Yield
-
Debt to Equity
0.41
KPL 52 Week High
₹3661.40
Kwality Pharmaceuticals 52 Week Low
₹1579.55
Operating Margin
25.00%
Profit Margin
15.82%
KPL Revenue (TTM)
₹158.00
EBITDA
₹40.00
Net Income
₹25.00
Total Assets
₹592.00
Total Equity
₹330.00
Kwality Pharmaceuticals Current Share Price Chart
Track the current Kwality Pharmaceuticals share price and stock price with an interactive chart. Analyse KPL price trends, trading volume, historical performance, and volatility across different timeframes — the complete Kwality Pharmaceuticals stock quote in one place.
Kwality Pharmaceuticals Company Profile - Fundamental Screener
Screen Kwality Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for KPL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE552U01010
Kwality Pharmaceuticals Balance Sheet Screener
Screen KPL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 592 | 447 | 394 | 354 | 341 | 166 | 133 | 105 | 96 | 71 |
| Current Assets | 406 | 284 | 243 | 207 | 228 | 106 | 89 | 75 | 75 | 53 |
| Fixed Assets | 156 | 146 | 139 | 121 | 92 | 57 | 43 | 29 | 20 | 17 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 37 | 15 | 20 | 29 | 21 | 28 | 20 | 8 | 6 | 4 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 330 | 262 | 223 | 199 | 180 | 60 | 45 | 36 | 29 | 25 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 5 |
| Reserves & Surplus | 321 | 254 | 214 | 190 | 171 | 51 | 36 | 27 | 19 | 20 |
Kwality Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen Kwality Pharmaceuticals income statement and profit fundamentals.
Analyze KPL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Kwality Pharmaceuticals share price evaluation.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 158 | 163 | 117 | 112 | 112 | 124 | 93 | 80 | 90 | 85 | 70 | 68 | 70 | 79 | 66 |
| Expenses | 118 | 121 | 90 | 87 | 86 | 94 | 78 | 63 | 70 | 67 | 74 | 54 | 54 | 61 | 48 |
| EBITDA | 40 | 42 | 27 | 25 | 26 | 30 | 14 | 18 | 20 | 18 | -4 | 14 | 16 | 17 | 18 |
| Operating Profit % | 25.00% | 25.00% | 22.00% | 22.00% | 23.00% | 24.00% | 15.00% | 22.00% | 22.00% | 21.00% | -7.00% | 20.00% | 22.00% | 21.00% | 25.00% |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 5 | 5 | 4 | 5 | 5 | 5 | 3 |
| Interest | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 1 |
| Profit Before Tax | 32 | 34 | 19 | 17 | 19 | 22 | 6 | 11 | 13 | 11 | -10 | 7 | 8 | 10 | 14 |
| Tax | 6 | 8 | 5 | 5 | 4 | 6 | 2 | 3 | 4 | 3 | -2 | 2 | 2 | 2 | 4 |
| Net Profit | 25 | 26 | 15 | 12 | 14 | 16 | 4 | 8 | 9 | 9 | -7 | 5 | 6 | 8 | 11 |
| EPS | 24.39 | 24.69 | 13.95 | 11.49 | 13.60 | 15.42 | 4.08 | 8.04 | 8.15 | 8.21 | -7.23 | 5.10 | 5.99 | 7.39 | 9.97 |
Kwality Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen KPL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 17 | 53 | 43 | 41 | 61 | 27 | 6 | 14 | -1 | 4 |
| Investing Activities | -35 | -29 | -26 | -48 | -63 | -23 | -18 | -12 | -6 | -7 |
| Financing Activities | 7 | -14 | -17 | 1 | 6 | 1 | 12 | -2 | 5 | 5 |
| Net Cash Flow | -11 | 10 | -1 | -6 | 3 | 4 | 0 | 0 | -1 | 2 |
Kwality Pharmaceuticals Shareholding Pattern Screener
See Kwality Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check Kwality Pharmaceuticals promoter holding and ownership changes for KPL on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 54.87% | 54.86% | 54.83% | 54.83% | 54.83% | 54.83% | 54.83% | 54.83% |
| FII Holding | 2.79% | 3.13% | 0.00% | 0.00% | 0.00% | 0.50% | 0.00% | 0.00% |
| DII Holding | 0.36% | 0.56% | 0.32% | 0.33% | 0.33% | 0.33% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 31.64% | 31.03% | 33.39% | 33.32% | 33.68% | 33.02% | 31.70% | 31.78% |
| Other Holding | 10.35% | 10.42% | 11.47% | 11.52% | 11.16% | 11.32% | 13.47% | 13.40% |
| Shareholder Count | 10,555 | 13,279 | 9,420 | 10,115 | 11,595 | 10,709 | 5,695 | 5,273 |
Kwality Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check Kwality Pharmaceuticals dividend history with payout and yield data.
View Kwality Pharmaceuticals dividend details including ex-dates and amounts for KPL stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.60 | 1.46% |
Kwality Pharmaceuticals Stock Index Membership
See which indices include Kwality Pharmaceuticals stock.
Check KPL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Kwality Pharmaceuticals Market Events Screener - Corporate Actions
Get Kwality Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check Kwality Pharmaceuticals stock events that may affect KPL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-31 | 2026-08-31 | Annual General Meeting | NA | 26.74% |
| 2026-08-10 | 2026-08-10 | Quarterly Result Announcement | NA | 1.00% |
| 2026-05-19 | 2026-05-19 | Quarterly Result Announcement | NA | 6.18% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 8.46% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -1.90% |
| 2025-09-09 | 2025-09-09 | Annual General Meeting | NA | -11.48% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | 0.73% |
| 2025-05-19 | 2025-05-19 | Quarterly Result Announcement | NA | 12.45% |
| 2025-01-31 | 2025-01-31 | Quarterly Result Announcement | NA | -2.47% |
| 2024-10-30 | 2024-10-30 | Quarterly Result Announcement | NA | -0.73% |
| 2024-09-24 | 2024-09-24 | Annual General Meeting | NA | 3.14% |
| 2017-10-11 | 2017-10-12 | Bonus | 1:1 | - |
Kwality Pharmaceuticals Competitors Screener - Peer Comparison
Screen KPL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 442,869 | 36.48 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 245,120 | 84.64 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 185,429 | 87.77 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 111,712 | 24.32 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 109,415 | 32.86 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 104,646 | 97.64 | 6,868 | 22.01% | 890 | 68.28 |
| Dr Reddys Laboratories | 95,987 | 30.44 | 35,059 | 3.90% | 4,158 | 47.72 |
| Aurobindo Pharma | 95,645 | 25.98 | 34,145 | 5.56% | 3,503 | 57.04 |
| Lupin | 94,533 | 17.27 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,019 | 45.49 | 14,636 | 14.85% | 1,938 | 37.57 |
Kwality Pharmaceuticals Company Announcements - News Screener
Screen KPL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-02 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-09-02 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-08-31 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-10 | Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 Under Regulation 33 Of The SEBI (LODR) Regulations 2015 | - |
| 2026-08-10 | Board Meeting Outcome for Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 Under Regulation 33 Of The SEBI (LODR) Regulations 2015 | - |
| 2026-08-09 | Notice Convening The 43Rd Annual General Meeting ("AGM") Of The Company On Monday 31St August 2026 At 12 :00 Noon. (IST) Through Video Conferencing (VC) / Other Audio Visual Means (OA VM). | - |
| 2026-08-09 | Reg. 34 (1) Annual Report. | - |
| 2026-08-08 | Intimation Of Book Closure | - |
| 2026-08-08 | Intimation Of 43Rd Annual General Meeting | - |
| 2026-08-08 | Board Meeting Outcome for Board Meeting Outcome For Intimation Of AGM | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-03 | Board Meeting Intimation for Consideration And Approval Of Standalone & Consolidated Unaudited Financial Results For The Quarter Ended 30-06-2026. | - |